21-hydroxylase deficiency other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(5 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{21-hydroxylase deficiency}}
{{21-hydroxylase deficiency}}
{{CMG}} {{MJ}}
{{CMG}}; {{AE}} {{MJ}}


==Overview==
==Overview==
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:[[amniotic fluid]] 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies; and utilize fetal DNA extracted from maternal blood through noninvasive methods.
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of [[congenital adrenal hyperplasia]]. Different tests which may be used are [[amniotic fluid]] testing and [[oligonucleotide]] hybridization of [[deoxyribonucleic acid]] (DNA) obtained from [[Chorionic villus sampling|chorionic villus samples]], and utilization of [[fetal]] [[DNA]] extracted from [[maternal]] [[blood]] through non-invasive methods.
==Other Diagnostic Studies==
==Other Diagnostic Studies==
Prenatal diagnosis for 21-hydroxylase deficiency  may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:
Prenatal diagnosis for 21-hydroxylase deficiency  may be used in diagnosis of [[congenital adrenal hyperplasia]]. Different tests which may be used are:
* [[Amniotic fluid]] testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies.
* [[Amniotic fluid]] testing and [[oligonucleotide]] hybridization of [[deoxyribonucleic acid]] ([[DNA]]) obtained from [[Chorionic villus sampling|chorionic villus samples]].
* Utilize fetal DNA extracted from maternal blood through noninvasive methods.<ref name="pmid27378492">{{cite journal |vauthors=Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T |title=New developments in prenatal diagnosis of congenital adrenal hyperplasia |journal=J. Steroid Biochem. Mol. Biol. |volume=165 |issue=Pt A |pages=121–123 |year=2017 |pmid=27378492 |doi=10.1016/j.jsbmb.2016.06.016 |url=}}</ref>
* Utilize [[fetal]] [[DNA]] extracted from [[maternal]] [[blood]] through non-invasive methods.<ref name="pmid27378492">{{cite journal |vauthors=Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T |title=New developments in prenatal diagnosis of congenital adrenal hyperplasia |journal=J. Steroid Biochem. Mol. Biol. |volume=165 |issue=Pt A |pages=121–123 |year=2017 |pmid=27378492 |doi=10.1016/j.jsbmb.2016.06.016 |url=}}</ref>
== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Disease]]
[[Category:Pediatrics]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Intersexuality]]
[[Category:Medicine]]
[[Category: Up-To-Date]]​

Latest revision as of 15:32, 24 July 2020

Congenital adrenal hyperplasia main page

21-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 21-Hydroxylase Deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

21-hydroxylase deficiency other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 21-hydroxylase deficiency other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 21-hydroxylase deficiency other diagnostic studies

CDC on 21-hydroxylase deficiency other diagnostic studies

21-hydroxylase deficiency other diagnostic studies in the news

Blogs on 21-hydroxylase deficiency other diagnostic studies

Directions to Hospitals Treating 21-Hydroxylase Deficiency

Risk calculators and risk factors for 21-hydroxylase deficiency other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus samples, and utilization of fetal DNA extracted from maternal blood through non-invasive methods.

Other Diagnostic Studies

Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:

References

  1. Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.

Template:WH Template:WS